Currently out of the existing stock ratings of Stan Berenshteyn, 56 are a BUY (50%), 5 are a SELL (4.46%), 51 are a HOLD (45.54%).

Stan Berenshteyn

Work Performance Price Targets & Ratings Chart

Analyst Stan Berenshteyn, currently employed at WELLS FARGO, carries an average stock price target met ratio of 62.47% that have a potential upside of 22.38% achieved within 155 days.

Stan Berenshteyn’s has documented 216 price targets and ratings displayed on 10 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on PHR, Phreesia at 03-Sep-2026.

Wall Street Analyst Stan Berenshteyn

Analyst best performing recommendations are on GDRX (GOODRX HOLDINGS).
The best stock recommendation documented was for GDRX (GOODRX HOLDINGS) at 11/9/2022. The price target of $5.5 was fulfilled within 2 days with a profit of $1.44 (35.47%) receiving and performance score of 177.34.

Average potential price target upside

OMCL Omnicell ACCD Accolade GDRX Goodrx Holdings HQY HealthEquity DOCS Doximity HCAT Health Catalyst TDOC Teladoc VEEV Veeva Systems AMWL American Well Corp PHR Phreesia

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 08-Aug-2022

$45

$11.4 (33.93%)

$49

2 months 2 days ago
(03-Aug-2026)

2/7 (28.57%)

$7.35 (19.52%)

94

Buy Since 23-May-2025

$50

$16.4 (48.81%)

$55

2 months 4 days ago
(31-Jul-2026)

17/23 (73.91%)

$14.63 (41.36%)

111

Buy Since 29-Apr-2026

$65

$31.4 (93.45%)

$70

2 months 4 days ago
(31-Jul-2026)

5/12 (41.67%)

$29.63 (83.77%)

100

Buy Since 01-Mar-2023

$60

$19.87 (49.51%)

$50

8 months 3 days ago
(02-Feb-2026)

18/25 (72%)

$11.3 (23.20%)

111

Hold Since 11-Nov-2024

$46

$12.4 (36.90%)

9 months 26 days ago
(09-Dec-2025)

7/9 (77.78%)

$2.51 (5.77%)

121

Show more analysts

Please expand the browser size to see the chart

Which stock is Stan Berenshteyn most bullish on?

Potential upside of $46.67 has been obtained for VEEV (VEEVA SYSTEMS)

Which stock is Stan Berenshteyn most reserved on?

Potential downside of -$9.93 has been obtained for DOCS (DOXIMITY)

What Year was the first public recommendation made by Stan Berenshteyn?

On 2021
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?